577P Impact of Homologous Recombination Deficiency (HRD) on Outcomes with Intraperitoneal (IP) and Intravenous (IV) Chemotherapy in Ovarian Cancer: Analyses from the Translational Ipocc Study (Tripocc)
Annals of oncology（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要